Trader consensus on Polymarket prices a 63.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, amid multiple active Level 2 alerts highlighting escalation risks from limited precautions. Recent catalysts include March 2026 activations for meningococcal disease in Democratic Republic of the Congo's Mangembo zone (March 24), yellow fever across Venezuela (March 16), chikungunya in Mayotte (March 10), and an updated global polio notice covering 30+ countries (March 9), reflecting rising circulating poliovirus detections. No Level 3 notices are currently active per CDC surveillance, but ongoing vaccine-preventable and vector-borne outbreaks, plus global measles upticks at Level 1, sustain trader expectations for threshold-crossing developments; watch weekly CDC updates and WHO epidemiological reports for shifts in case counts and transmission dynamics.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Le CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Oui
$115,732 Vol.
$115,732 Vol.
Oui
$115,732 Vol.
$115,732 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus on Polymarket prices a 63.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, amid multiple active Level 2 alerts highlighting escalation risks from limited precautions. Recent catalysts include March 2026 activations for meningococcal disease in Democratic Republic of the Congo's Mangembo zone (March 24), yellow fever across Venezuela (March 16), chikungunya in Mayotte (March 10), and an updated global polio notice covering 30+ countries (March 9), reflecting rising circulating poliovirus detections. No Level 3 notices are currently active per CDC surveillance, but ongoing vaccine-preventable and vector-borne outbreaks, plus global measles upticks at Level 1, sustain trader expectations for threshold-crossing developments; watch weekly CDC updates and WHO epidemiological reports for shifts in case counts and transmission dynamics.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes